Inventor
BITONTI ALAN J
US42 patents
⚠️ This page may combine multiple inventors who share the name “BITONTI ALAN J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MERRELL PHARMA INC
7 patentsUS5593664AJan 14, 1997
Antiangiogenic oligomers
MERRELL PHARMA INC21 citations92
US6107275AAug 22, 2000
Cyclic Antiplatelet peptides with pseudo-bond
MERRELL PHARMA INC10 citations74
US5607925AMar 4, 1997
Treatment of carcinoma by administration of 2'-halomethylidenyl-2'-deoxynucleosides
MERRELL PHARMA INC12 citations74
US5684004ANov 4, 1997
Triaryl-ethylene derivatives
MERRELL PHARMA INC9 citations73
US5681863AOct 28, 1997
Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
MERRELL PHARMA INC6 citations70
US5610171AMar 11, 1997
Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones
MERRELL PHARMA INC4 citations63
US5753714AMay 19, 1998
Polyamine derivatives
MERRELL PHARMA INC5 citations62
MERRELL DOW PHARMA
7 patentsUS4935449AJun 19, 1990
N-2,3-butadienyl tri- and tetraaminoalkane derivatives
MERRELL DOW PHARMA28 citations92
US5525633AJun 11, 1996
Triaryl-ethylene derivatives
MERRELL DOW PHARMA12 citations73
US5134168AJul 28, 1992
Phenoxy and phenylthio, amino substituted benzocycloalkane derivatives in the treatment and prevention of drug-resistant protozoal infections
MERRELL DOW PHARMA16 citations73
US5373005ADec 13, 1994
Despiramine in the treatment of drug-resistant malarial infections
MERRELL DOW PHARMA8 citations72
US5182387AJan 26, 1993
Bis-dibenzoazepine compounds
MERRELL DOW PHARMA4 citations62
US5214050AMay 25, 1993
Esters of castanospermine in the treatment of cerebral malaria
MERRELL DOW PHARMA6 citations61
US5410080AApr 25, 1995
Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors
MERRELL DOW PHARMA2 citations59
BIOVERATIV THERAPEUTICS INC
7 patentsUS11266720B2Mar 8, 2022
Factor VIII-FC chimeric and hybrid polypeptides, and methods of use thereof
BIOVERATIV THERAPEUTICS INC6 citations84
US9725496B1Aug 8, 2017
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC4 citations84
US10881742B2Jan 5, 2021
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
BIOVERATIV THERAPEUTICS INC5 citations83
US10023628B2Jul 17, 2018
Cell line expressing single chain factor VIII polypeptides and uses thereof
BIOVERATIV THERAPEUTICS INC6 citations83
US12186375B2Jan 7, 2025
Factor VIII chimeric and hybrid polypeptides, and methods of use thereof
BIOVERATIV THERAPEUTICS INC1 citations73
US11168125B2Nov 9, 2021
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC1 citations73
US11401322B2Aug 2, 2022
Immunoglobulin chimeric monomer-dimer hybrids
BIOVERATIV THERAPEUTICS INC0 citations62
SYNTONIX PHARMACEUTICALS INC
6 patentsUS7862820B2Jan 4, 2011
Immunoglobulin chimeric monomer-dimer hybrids
SYNTONIX PHARMACEUTICALS INC120 citations98
US7404956B2Jul 29, 2008
Immunoglobulin chimeric monomer-dimer hybrids
SYNTONIX PHARMACEUTICALS INC301 citations98
US7348004B2Mar 25, 2008
Immunoglobulin chimeric monomer-dimer hybrids
SYNTONIX PHARMACEUTICALS INC218 citations98
US7566565B2Jul 28, 2009
PC5 as a factor IX propeptide processing enzyme
SYNTONIX PHARMACEUTICALS INC44 citations96
US8021880B2Sep 20, 2011
PC5 as a factor IX propeptide processing enzyme
SYNTONIX PHARMACEUTICALS INC17 citations92
US7795400B2Sep 14, 2010
PC5 as a factor IX propeptide processing enzyme
SYNTONIX PHARMACEUTICALS INC10 citations84
AVENTIS PHARMA INC
3 patentsUS6413974B1Jul 2, 2002
6,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines
AVENTIS PHARMA INC94 citations96
US6479487B1Nov 12, 2002
6, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
AVENTIS PHARMA INC78 citations95
US6642231B2Nov 4, 2003
6,9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purines
AVENTIS PHARMA INC1 citations51
BIOGEN IDEC HEMOPHILIA INC
2 patentsTENHOOR CHRISTOPHER
2 patentsHOECHST MARION ROUSSEL INC
2 patentsUS5693674ADec 2, 1997
Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
HOECHST MARION ROUSSEL INC16 citations74
US5691384ANov 25, 1997
Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis
HOECHST MARION ROUSSEL INC0 citations52